These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 9033638)
1. bcl-2 over-expression delays radiation-induced apoptosis without affecting the clonogenic survival of human prostate cancer cells. Kyprianou N; King ED; Bradbury D; Rhee JG Int J Cancer; 1997 Jan; 70(3):341-8. PubMed ID: 9033638 [TBL] [Abstract][Full Text] [Related]
2. Radiation-induced apoptosis of human prostate cancer cells is independent of mutant p53 overexpression. Kyprianou N; Rock S Anticancer Res; 1998; 18(2A):897-905. PubMed ID: 9615738 [TBL] [Abstract][Full Text] [Related]
3. Overexpression of the cytoprotective protein clusterin decreases radiosensitivity in the human LNCaP prostate tumour model. Zellweger T; Kiyama S; Chi K; Miyake H; Adomat H; Skov K; Gleave ME BJU Int; 2003 Sep; 92(4):463-9. PubMed ID: 12930442 [TBL] [Abstract][Full Text] [Related]
4. Dichloroacetate (DCA) sensitizes both wild-type and over expressing Bcl-2 prostate cancer cells in vitro to radiation. Cao W; Yacoub S; Shiverick KT; Namiki K; Sakai Y; Porvasnik S; Urbanek C; Rosser CJ Prostate; 2008 Aug; 68(11):1223-31. PubMed ID: 18465755 [TBL] [Abstract][Full Text] [Related]
5. Cell death in irradiated prostate epithelial cells: role of apoptotic and clonogenic cell kill. Bromfield GP; Meng A; Warde P; Bristow RG Prostate Cancer Prostatic Dis; 2003; 6(1):73-85. PubMed ID: 12664070 [TBL] [Abstract][Full Text] [Related]
6. Didox (a novel ribonucleotide reductase inhibitor) overcomes Bcl-2 mediated radiation resistance in prostate cancer cell line PC-3. Inayat MS; Chendil D; Mohiuddin M; Elford HL; Gallicchio VS; Ahmed MM Cancer Biol Ther; 2002; 1(5):539-45. PubMed ID: 12496485 [TBL] [Abstract][Full Text] [Related]
7. Caspase-1 enhances the apoptotic response of prostate cancer cells to ionizing radiation. Winter RN; Rhee JG; Kyprianou N Anticancer Res; 2004; 24(3a):1377-86. PubMed ID: 15274298 [TBL] [Abstract][Full Text] [Related]
8. Sphingolipids and the sphingosine kinase inhibitor, SKI II, induce BCL-2-independent apoptosis in human prostatic adenocarcinoma cells. Leroux ME; Auzenne E; Evans R; Hail N; Spohn W; Ghosh SC; Farquhar D; McDonnell T; Klostergaard J Prostate; 2007 Nov; 67(15):1699-717. PubMed ID: 17879964 [TBL] [Abstract][Full Text] [Related]
9. Ionizing radiation enhances the therapeutic potential of TRAIL in prostate cancer in vitro and in vivo: Intracellular mechanisms. Shankar S; Singh TR; Srivastava RK Prostate; 2004 Sep; 61(1):35-49. PubMed ID: 15287092 [TBL] [Abstract][Full Text] [Related]
10. Antisense Bcl-2 sensitizes prostate cancer cells to radiation. Mu Z; Hachem P; Pollack A Prostate; 2005 Dec; 65(4):331-40. PubMed ID: 16015611 [TBL] [Abstract][Full Text] [Related]
11. Suppression of prostate tumor cell growth in vivo by WT1, the Wilms' tumor suppressor gene. Fraizer G; Leahy R; Priyadarshini S; Graham K; Delacerda J; Diaz M Int J Oncol; 2004 Mar; 24(3):461-71. PubMed ID: 14767530 [TBL] [Abstract][Full Text] [Related]
12. Enhanced radiation sensitivity in prostate cancer by inhibition of the cell survival protein clusterin. Zellweger T; Chi K; Miyake H; Adomat H; Kiyama S; Skov K; Gleave ME Clin Cancer Res; 2002 Oct; 8(10):3276-84. PubMed ID: 12374699 [TBL] [Abstract][Full Text] [Related]
13. Par-4, a pro-apoptotic gene, inhibits radiation-induced NF kappa B activity and Bcl-2 expression leading to induction of radiosensitivity in human prostate cancer cells PC-3. Chendil D; Das A; Dey S; Mohiuddin M; Ahmed MM Cancer Biol Ther; 2002; 1(2):152-60. PubMed ID: 12170775 [TBL] [Abstract][Full Text] [Related]
14. Alpha1-adrenoceptor antagonists radiosensitize prostate cancer cells via apoptosis induction. Cuellar DC; Rhee J; Kyprianou N Anticancer Res; 2002; 22(3):1673-9. PubMed ID: 12168853 [TBL] [Abstract][Full Text] [Related]
15. 7-hydroxystaurosporine (UCN-01) and ionizing radiation combine to inhibit the growth of Bcl-2-overexpressing U937 leukemia cells through a non-apoptotic mechanism. Cartee L; Sankala H; Davis C; Smith R; Maggio S; Lin PS; Dent P; Grant S Int J Oncol; 2002 Aug; 21(2):351-9. PubMed ID: 12118331 [TBL] [Abstract][Full Text] [Related]
16. Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis. Guo Y; Kyprianou N Cancer Res; 1999 Mar; 59(6):1366-71. PubMed ID: 10096572 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo. Raffo AJ; Perlman H; Chen MW; Day ML; Streitman JS; Buttyan R Cancer Res; 1995 Oct; 55(19):4438-45. PubMed ID: 7671257 [TBL] [Abstract][Full Text] [Related]
18. Combined antitumor effect of suramin plus irradiation in human prostate cancer cells: the role of apoptosis. Sklar GN; Eddy HA; Jacobs SC; Kyprianou N J Urol; 1993 Nov; 150(5 Pt 1):1526-32. PubMed ID: 8411447 [TBL] [Abstract][Full Text] [Related]
19. Direct evidence that apoptosis enhances tumor responses to fractionated radiotherapy. Rupnow BA; Murtha AD; Alarcon RM; Giaccia AJ; Knox SJ Cancer Res; 1998 May; 58(9):1779-84. PubMed ID: 9581811 [TBL] [Abstract][Full Text] [Related]
20. Bcl-2 antagonizes the combined apoptotic effect of transforming growth factor-beta and dihydrotestosterone in prostate cancer cells. Bruckheimer EM; Kyprianou N Prostate; 2002 Oct; 53(2):133-42. PubMed ID: 12242728 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]